|
AU2020103878A4
|
|
Compounds and methods for treating influenza
|
|
CN112089835A
|
|
Pharmaceutical composition comprising a non-coding RNA molecule and an antibody targeting a tumor antigen
|
|
CN112194703A
|
|
Cardiac glycoside compound and synthesis method and application thereof
|
|
CN112116625A
|
|
Automatic heart CT image segmentation method, device and medium based on contradiction marking method
|
|
CN112116957A
|
|
Disease subtype prediction method, system, device and medium based on small sample
|
|
CN111773301A
|
|
Composition containing aloe extract and application thereof
|
|
CN111848722A
|
|
Tripterine derivative and preparation method and application thereof
|
|
CN111574580A
|
|
Ginsenoside derivative and synthesis method and application thereof
|
|
CN111362894A
|
|
NHTD (polyethylene glycol terephthalate) synthesis method
|
|
CN111763669A
|
|
Double-stranded RNA molecule and application thereof
|
|
CN110894537A
|
|
PCR (polymerase chain reaction) primer, kit and method for identifying authenticity of cordyceps sinensis and commercial product thereof
|
|
AU2019101124A4
|
|
Method of diagnosing systemic lupus erythematosus
|
|
AU2019101081A4
|
|
Method of inhibiting or treating cardiovascular disorder
|
|
WO2021035391A1
|
|
Use of transfer rna molecule and fragment thereof in prevention or treatment of heart disease
|
|
CN111419867A
|
|
Use of transport RNA molecules and fragments thereof for preventing or treating cardiac diseases
|
|
CN110478320A
|
|
Carry the meso-porous titanium dioxide silicon-agent and preparation method thereof of S- S-propargyl-cysteine
|
|
CN110496105A
|
|
A kind of microball preparation and preparation method thereof carrying S- S-propargyl-cysteine
|
|
CN110327379A
|
|
A kind of activation fatty acid-g protein coupled receptor access composition
|
|
CN110170053A
|
|
Composition, its preparing in immunotherapy of tumors drug application and pharmaceutical composition
|
|
AU2018102089A4
|
|
Method of treating endotoxemia
|
